Mckinley Capital Management LLC Atai Life Sciences N.V. Transaction History
Mckinley Capital Management LLC
- $558 Million
- Q2 2024
Shares
2 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.7MCall Options Held
9.2KPut Options Held
118K-
Walleye Capital LLC Plymouth, MN2.76MShares$3.23 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.72MShares$3.18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.53 Million0.0% of portfolio
-
Brown University719KShares$840,6450.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$839,0430.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $194M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...